Back to Ss-31 research
ss-31 mitochondrial peptide preclinical animal n preclinical 2026-04-03 PubMed

SS-31 Peptide Protects Brain Cells from Damage in Epilepsy

Mitochondria-targeting peptide SS-31 attenuates ferroptosis via inhibition of the p38 MAPK signaling pathway in the hippocampus of epileptic rats.

Background

Epilepsy is a chronic neurological disorder characterized by recurrent seizures, which can lead to significant neuronal damage and cognitive impairment over time. Recent scientific investigations have increasingly implicated ferroptosis, a distinct form of regulated cell death driven by iron-dependent lipid peroxidation, as a crucial contributor to the neuronal injury observed following epileptic seizures. While the involvement of the p38 MAPK signaling pathway in mediating seizure-induced neuronal death is well-established, the precise mechanisms by which this pathway contributes to ferroptosis in the hippocampus during epilepsy, and the potential for therapeutic intervention targeting this specific process, have remained an important knowledge gap.


ss-31 mitochondrial peptide mapk-erk
Source: pubmed:38521160 · Ingested 2026-04-03 · Digest: gemini-2.5-flash